Late complications of immune deviation therapy in a nonhuman primate

被引:292
作者
Genain, CP
Abel, K
Belmar, N
Villinger, F
Rosenberg, DP
Linington, C
Raine, CS
Hauser, SL
机构
[1] EMORY UNIV,SCH MED,DEPT PATHOL & LAB MED,ATLANTA,GA 30322
[2] MAX PLANCK INST PSYCHIAT,DEPT NEUROIMMUNOL,D-8033 MARTINSRIED,GERMANY
[3] ALBERT EINSTEIN COLL MED,DEPT PATHOL,BRONX,NY 10461
关键词
D O I
10.1126/science.274.5295.2054
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The administration of antigens in soluble form can induce antigen-specific immune tolerance and suppress experimental autoimmune diseases, In a marmoset model of multiple sclerosis induced by myelin oligodendrocyte glycoprotein (MOG), marmosets tolerized to MOG were protected against acute disease, but after tolerization treatment a lethal demyelinating disorder emerged. In these animals, MOG-specific T cell proliferative responses were transiently suppressed, cytokine production was shifted from a T helper type 1 (T(H)1) to a T(H)2 pattern, and titers of autoantibodies to MOG were enhanced. Thus, immune deviation can increase concentrations of pathogenic autoantibodies and in some circumstances exacerbate autoimmune disease.
引用
收藏
页码:2054 / 2057
页数:4
相关论文
共 43 条
  • [1] AMOR S, 1994, J IMMUNOL, V153, P4349
  • [2] [Anonymous], 1983, MULTIPLE SCLEROSIS P
  • [3] SURFACE EXPRESSION OF ALPHA-4 INTEGRIN BY CD4 T-CELLS IS REQUIRED FOR THEIR ENTRY INTO BRAIN PARENCHYMA
    BARON, JL
    MADRI, JA
    RUDDLE, NH
    HASHIM, G
    JANEWAY, CA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (01) : 57 - 68
  • [4] Mechanisms of immune injury in multiple sclerosis
    Brosnan, CF
    Raine, CS
    [J]. BRAIN PATHOLOGY, 1996, 6 (03) : 243 - 257
  • [5] REGULATORY T-CELL CLONES INDUCED BY ORAL TOLERANCE - SUPPRESSION OF AUTOIMMUNE ENCEPHALOMYELITIS
    CHEN, YH
    KUCHROO, VK
    INOBE, J
    HAFLER, DA
    WEINER, HL
    [J]. SCIENCE, 1994, 265 (5176) : 1237 - 1240
  • [6] IMMUNOCYTOCHEMICAL LOCALIZATION OF THE TERMINAL COMPLEMENT COMPLEX IN MULTIPLE-SCLEROSIS
    COMPSTON, DAS
    MORGAN, BP
    CAMPBELL, AK
    WILKINS, P
    COLE, G
    THOMAS, ND
    JASANI, B
    [J]. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1989, 15 (04) : 307 - 316
  • [7] T-CELL DELETION IN HIGH ANTIGEN DOSE THERAPY OF AUTOIMMUNE ENCEPHALOMYELITIS
    CRITCHFIELD, JM
    RACKE, MK
    ZUNIGAPFLUCKER, JC
    CANNELLA, B
    RAINE, CS
    GOVERMAN, J
    LENARDO, MJ
    [J]. SCIENCE, 1994, 263 (5150) : 1139 - 1143
  • [8] LONG-TERM INHIBITION OF MURINE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS USING CTLA-4-FC SUPPORTS A KEY ROLE FOR CD28 COSTIMULATION
    CROSS, AH
    GIRARD, TJ
    GIACOLETTO, KS
    EVANS, RJ
    KEELING, RM
    LIN, RF
    TROTTER, JL
    KARR, RW
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) : 2783 - 2789
  • [9] VESICULAR DISRUPTION OF MYELIN IN AUTOIMMUNE DEMYELINATION
    DALCANTO, MC
    WISNIEWSKI, HM
    JOHNSON, AB
    BROSTOFF, SW
    RAINE, CS
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1975, 24 (03) : 313 - 319
  • [10] REACTIVITY TO MYELIN ANTIGENS IN MULTIPLE-SCLEROSIS - PERIPHERAL-BLOOD LYMPHOCYTES RESPOND PREDOMINANTLY TO MYELIN OLIGODENDROCYTE GLYCOPROTEIN
    DEROSBO, NK
    MILO, R
    LEES, MB
    BURGER, D
    BERNARD, CCA
    BENNUN, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) : 2602 - 2608